Chong Kun Dang successful in patent challenge for Avodart
As successful in the patent challenge for the prostatic and alopecia treatment, ‘Avodart(dutasteride, GSK),’ Chong Kun Dang raised a chance to launch its follow-up drug on its own.
On the 11th, the Intellectual Property Tribunal ruled Chong Kun Dang has not infringed on the patent right of the a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
